Plus Therapeutics regains Nasdaq compliance on two listing rules; bid price deadline extended to Nov 12, 2025

PLUS THERAPEUTICS, INC.

Nasdaq confirmed compliance with MVLS ($35M) and equity ($2.5M) standards on Aug 22, 2025.
Bid price rule deadline extended to Nov 12, 2025; prior Sept 8 deadline no longer applies.
One-year monitoring for equity standard through Aug 22, 2026; breach triggers delist process without cure period.
Company now satisfies two alternative criteria under Nasdaq Listing Rule 5550.

item 8.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-188075
form_type: 8-K
ticker: PSTV
cik: 0001095981
company_name: PLUS THERAPEUTICS, INC.
filed_at: 2025-08-26T23:59:59+00:00
discovered_at: 2026-05-14T18:02:43.328118+00:00
generated_at: 2026-05-17T09:53:24.849540+00:00
sec_items: ["8.01"]
event_type: regulatory
sentiment: positive
materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-188075
json_url: https://secwatch.observer/filing/0001193125-25-188075.json
markdown_url: https://secwatch.observer/filing/0001193125-25-188075.md
text_url: https://secwatch.observer/filing/0001193125-25-188075.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1095981/000119312525188075/0001193125-25-188075-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1095981/000119312525188075/d919644d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-25-188075

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.